Chemo/chemodynamic synergistic
therapy is a promising strategy to improve the antitumor effect. However,
hypoxia and a limited amount of
hydrogen peroxide (H2O2) in the tumor microenvironment (TME) severely restrict the therapeutic efficacy of this combined treatment. Herein, we report biodegradable
doxorubicin (Dox)-loaded
copper-
metformin (Met) nanoscale coordination
polymers (Dox@Cu-Met NPs), which exert a chemo/chemodynamic synergistic
therapeutic effect by reducing
oxygen (O2) consumption to promote H2O2 accumulation in the
tumor. Inside
tumor cells, Met can inhibit the consumption of O2 to relieve tumor hypoxia by suppressing mitochondrial respiration. The alleviated-tumor hypoxia can not only elevate H2O2 content via the Dox-activated cascade reaction of
nicotinamide adenine dinucleotide phosphate (
NADPH) oxidases (NOXs) and
superoxide dismutase (SOD), but also improve the efficacy of Dox. More importantly, the depletion of
glutathione (GSH) accompanies the whole treatment process, which can realize the conversion of Cu2+ to Cu+ and boost
reactive oxygen species (ROS) accumulation to improve chemodynamic
therapy (CDT) efficacy. Meanwhile, Met is expected to cut off the energy supply by inhibiting respiration, leading to
starvation therapy. In vivo investigations demonstrate that
tumor growth is significantly inhibited through the enhanced chemo/chemodynamic synergistic treatment. This work provides a new paradigm for
cancer therapy using an economical and straightforward method to construct a synergistic nanomedicine platform.